Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate?

Key Takeaways HOLX pulled the HIV testing business in Africa from its 2025 forecast after USAID halted funding support. Tariffs from China and Costa Rica are set to increase HOLX's inventory costs by up to $25M per quarter. Hologic's Diagnostics momentum is driven by strong BV/CV test demand and Panther utilization growth.Marlborough, MA-based Hologic (HOLX) is navigating a shifting geopolitical landscape in each of its core businesses. In a conservative move, the company’s fiscal 2025 sales outlook now e ...